Caesar Ventures
VC Fund
Munich, Germany
Caesar Ventures is a venture capital firm.
- Total investments:
- 30
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Caesar Ventures invests in
Stages Caesar Ventures invests in
Countries Caesar Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.6M–$7.6M
- Pre-Seed
- $1.1M–$3M
Investment Focus
Industry
- Artificial Intelligence 6 (20%)
- Health Care 3 (10%)
- Information Technology 3 (10%)
- SaaS 2 (7%)
- Internet 2 (7%)
Stage
- Seed 11 (37%)
- Pre-Seed 11 (37%)
- Series A 1 (3%)
Country
- Germany 11 (37%)
- United States 3 (10%)
- Israel 1 (3%)
- Czech Republic 1 (3%)
- United Kingdom 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Gregor Unger
Managing Partner
|
Managing Partner | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Aisel is a psychiatry AI tool for clinicians that makes clinical documents safer to sign. General scribes transcribe a conversation into a note; Aisel works on the documents where being wrong is expensive — expert court reports, tribunal and Mental Health Act reports, medico-legal certificates, capability and benefits reports.Upload thepatient's records once and generate what the case needs. Every statement is cited to its source with side-by-side verification. Contradictions between records — or with the patient's account — are flagged for your judgment, and a completeness check measures the report against what it must answer, so gaps surface while they're still fixable.Aisel never generates opinions: it assembles, cites and checks the evidence; the clinician authors the conclusions and signs. GDPR-compliant, ISO 27001-compliant, end-to-end encrypted, UK/EU data residency, patient data deleted at discharge. | $2M / Pre-Seed / Aug 19, 2026 | ||
| Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity. | $2.3M / Pre-Seed / Jun 30, 2026 | ||
| Qorelo is a tech company that provides agentic AI software designed to accelerate ERP transformations. Qorelo's software automates and structures deliverables across the SAP Activate methodology. | $3.5M / Seed / Jun 14, 2026 | ||
| CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer. | $6.9M / Seed / Jun 12, 2026 | ||
| Freshflow is harnessing AI to build the food supply chain technology of the future and tackle global food waste. | $10M / Series A / Jun 03, 2026 | ||
| nu:legal is a unique legal system designed for European businesses in collaboration with top lawyers and law firms. | $1.5M / Seed / May 27, 2026 | ||
| BLOCKS deploys an AI agent to monitor cloud usage patterns continuously. The agent identifies wasteful resource allocations and applies real-time optimizations autonomously. It differs from dashboards by taking direct action instead of just alerting users. | $6M / Pre-Seed / Apr 09, 2026 | ||
| YOUTH uses data collected from smartphone sensors and machine learning to make prevention easily accessible. With a face video, audio recording and an eye picture YOUTH can screen your health status in under 2 minutes, and detect early signs of health risks for 10+ organs and 49+ biomarkers. | $4.5M / Seed / Feb 25, 2026 | ||
| Cyberdesk provides IT solutions and management. | Seed / Feb 06, 2026 | ||
| The A&B Smart Materials Using innovative cooling technologies to boost photovoltaic efficiency. | $2M / Pre-Seed / Dec 12, 2025 | ||
| See all 30 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Caesar Ventures invest in?
Caesar Ventures invests primarily in Artificial Intelligence, Health Care and Information Technology startups, most often at Seed and Pre-Seed stage. Most of the 30 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Caesar Ventures's check size?
Caesar Ventures typically joins rounds of $1.6M–$7.6M at Seed and $1.1M–$3M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Caesar Ventures participates in.
How do I contact Caesar Ventures?
Public channels for Caesar Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Caesar Ventures?
The team at Caesar Ventures includes Gregor Unger (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
